M. Herman Chui

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)”.

Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.07.005

N/A

1.5DataRank · unranked

41 citations

William G. Richards, David H. Harpole, Karla V. Ballman, Ming-Sound Tsao, Zhengming Chen +18 more

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic Oncology(2024)10.1016/j.ygyno.2023.12.028

N/A

0.583DataRank · unranked

12 citations

M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen +9 more

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.008

N/A

0.457DataRank · unranked

20 citations

Mackenzie W. Sullivan, Qin Zhou, Alexia Iasonos, Pier Selenica, Chrystal Stallworth +9 more

Molecular subtypes and genomic landscape of undifferentiated and dedifferentiated endometrial cancer

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101815

N/A

0.208DataRank · unranked

3 citations

Pier Selenica, Amir Momeni Boroujeni, Lora H. Ellenson, Jennifer J. Mueller, Nadeem R. Abu‐Rustum +3 more

Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors

Modern Pathology(2022)10.1038/s41379-022-01160-1

N/A

0DataRank · unranked

21 citations

Elizabeth Kertowidjojo, Xinyu Wu, Robert A. Soslow, Sarah Chiang, Edaise M. da Silva +3 more

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

Scientific Reports(2022)10.1038/s41598-021-04618-5

N/A

0DataRank · unranked

33 citations

Beryl Manning‐Geist, Christina Henson, Gopa Iyer, Ginger J. Gardner, Yukio Sonoda +5 more

Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors

Research Square(2022)10.21203/rs.3.rs-1702918/v1

N/A

0DataRank · unranked

2 citations

Elizabeth Kertowidjojo, Xinyu Wu, Robert A. Soslow, Sarah Chiang, Edaise da Silva +3 more

HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer

Modern Pathology(2023)10.1016/j.modpat.2023.100299

N/A

0DataRank · unranked

21 citations

Weining Ma, David N. Brown, Arnaud Da Cruz Paula, Qin Zhou, Alexia Iaosonos +11 more

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

Cancer(2023)10.1002/cncr.34753

N/A

0DataRank · unranked

19 citations

Ryan Kahn, David Nemirovsky, Jeffrey Girshman, Anya Laibangyang, Sushmita Gordhandas +8 more

The highs and lows of serous ovarian cancer

Cancer(2023)10.1002/cncr.34903

N/A

0DataRank · unranked

15 citations

Beryl Manning‐Geist, M. Herman Chui, Rachel N. Grisham

Decreased HER2 expression in endometrial cancer following anti‐HER2 therapy

The Journal of Pathology(2023)10.1002/path.6230

N/A

0DataRank · unranked

11 citations

David N. Brown, Arnaud Da Cruz Paula, Edaise M. da Silva, Amir Momeni Boroujeni, Jorge S. Reis‐Filho +5 more

Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status

International Journal of Gynecological Pathology(2023)10.1097/pgp.0000000000000933

N/A

0DataRank · unranked

10 citations

Rajmohan Murali, Robert A. Soslow, Cathleen Matrai, Deyin Xing, Russell Vang +1 more

Beyond the estrogen receptor: In search of predictive biomarkers for low‐grade serous ovarian cancer

Cancer(2023)10.1002/cncr.34658

N/A

0DataRank · unranked

2 citations

Beryl Manning‐Geist, M. Herman Chui, Rachel N. Grisham

Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions

The American Journal of Surgical Pathology(2024)10.1097/pas.0000000000002187

N/A

0DataRank · unranked

31 citations

Yeh Wang, Peng Huang, Barrett C. Lawson, David L. Kolin, M. Herman Chui +11 more

Early Genetic Divergence of High-Grade Carcinomas Originating from Low-Grade Serous Ovarian Neoplasms

Modern Pathology(2024)10.1016/j.modpat.2024.100629

N/A

0DataRank · unranked

12 citations

Qianqian Song, Jiarun Zhu, Yuchen Jiao, Brant G. Wang, Yeh Wang +4 more

Molecular profiling of primary endometrioid endometrial cancer and matched lung metastases: CTNNB1 mutation as a potential driver

Gynecologic Oncology Reports(2024)10.1016/j.gore.2024.101391

N/A

0DataRank · unranked

2 citations

Arnaud Da Cruz Paula, Elizabeth Kertowidjojo, Fresia Pareja, Kimberly Dessources, Edaise M. da Silva +6 more

ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability‐high ( MSI ‐H) molecular subtype

Molecular Oncology(2024)10.1002/1878-0261.13698

N/A

0DataRank · unranked

2 citations

Pier Selenica, Weining Ma, Sara Moufarrij, Christian Dagher, Thais Basili +8 more

Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3168

N/A

0DataRank · unranked

6 citations

Eun-Young Kang, Ryan Kahn, Sarah Chiang, Qin Zhou, Alexia Iasonos +7 more

TROP2 expression and therapeutic targeting in uterine carcinosarcoma

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.590

N/A

0DataRank · unranked

6 citations

Higinio Dopeso, David N. Brown, Hunter Green, Kaitlyn Gill, Julia Tengelin +16 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023

N/A

0DataRank · unranked

2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions

Cancer Research(2025)10.1158/0008-5472.can-25-3189

N/A

0DataRank · unranked

2 citations

Yen‐Wei Chien, S. S. Chen, Annelise Sokolow, Yeh Wang, Brant G. Wang +10 more

Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.021

N/A

0DataRank · unranked

2 citations

M. Herman Chui, Pier Selenica, Kara Long Roche, Yukio Sonoda, Rachel N. Grisham +6 more

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas

Modern Pathology(2021)10.1038/s41379-021-00997-2

N/A

0DataRank · unranked

78 citations

Kelly A. Devereaux, Cao Jin, David YunTe Lin, Yanming Zhang, Antonio Marra +5 more

Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab117

N/A

0DataRank · unranked

19 citations

Pier Selenica, M. Herman Chui, Gowtham Jayakumaran, Ryan Ptashkin, Maksym Misyura +20 more

Deep Interactive Learning-based ovarian cancer segmentation of H&E-stained whole slide images to study morphological patterns of BRCA mutation

Journal of Pathology Informatics(2022)10.1016/j.jpi.2022.100160

N/A

0DataRank · unranked

36 citations

M. Herman Chui, Chad Vanderbilt, Ji‐Won Jung, Mark E. Robson, Chan-Sik Park +3 more